Deadly brain disease could be treated in the womb with gene therapy

| | July 25, 2018
PRinc photo of fetus at weeks
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

A research team from the UK and Singapore showed that a neurodegenerative condition called Gaucher disease, which can be fatal, can be prevented in mice by treating fetuses with gene therapy.

The study, published in Nature Medicine, showed mice fetuses with Gaucher disease that received an injection of the gene therapy were able to express the missing enzyme. Furthermore, animals treated with the gene therapy lived for four and a half months after birth compared to 15 days for untreated mice.

While the findings underscore the potential of using gene therapy to prevent and cure fetal diseases in humans in utero, the approach is still a long way from being tested in humans.

Related article:  Genetic therapies won't solve depression anytime soon

Read full, original post: Gene Therapy Could Prevent Deadly Brain Disease

 

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend